title: Comparison of endothelial function in patients with metabolic syndrome on bezafibrate or atorvastatin therapy.
authors: Heart and Vascular Center Bochum, Department of Medicine II, St. Josef-Hospital, University of Bochum, Germany.
authors: Christoph
authors: C
authors: Hanefeld
authors: Nadine
authors: N
authors: Bulut-Streich
authors: Daniel
authors: D
authors: Bulut
authors: Claudia
authors: C
authors: Graf
authors: Andreas
authors: A
authors: Mügge
authors: Martin
authors: M
authors: Spiecker
mesh_terms: D000368:Aged; D000069059:Atorvastatin; D001629:Bezafibrate / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood / Q000187:drug effects; D008078:Cholesterol, LDL / Q000097:blood / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000503:physiopathology*; D005542:Forearm / Q000098:blood supply; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D015228:Hypertriglyceridemia / Q000188:drug therapy / Q000503:physiopathology; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D024821:Metabolic Syndrome / Q000188:drug therapy* / Q000503:physiopathology*; D008875:Middle Aged; D011758:Pyrroles / Q000627:therapeutic use*; D012039:Regional Blood Flow / Q000187:drug effects; D016896:Treatment Outcome; D014664:Vasodilation / Q000187:drug effects
chemical_list: D015415:Biomarkers; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D011758:Pyrroles; D000069059:Atorvastatin; D001629:Bezafibrate